Article

Rare Tumors Require Different Strategies in Mohs Disease

Conference|EADV Congress - European Academy of Dermatology and Venereology Congress

Aleksandar L. Krunic, MD, PhD, discusses treatment strategies for rare tumor types in Mohs disease during the 25th European Academy of Dermatology and Venereology Congress.

Aleksandar L. Krunic, MD, PhD, dermatologic surgeon and assistant professor of dermatology at University of Illinois College of Medicine, discusses how rare tumors need to be treated differently during therapy for Mohs disease.

Related Videos
Hands holding a crochet heart | Image Credit: © StockerThings - stock.adobe.com
Wooden blocks spelling HDL, LDL | Image Credit: © surasak - stock.adobe.com
Anticoagulant attacking blood clot | Image Credit: © BURIN93 - stock.adobe.com
Depiction of man aging | Image Credit: © Top AI images - stock.adobe.com
Map with pins | Image Credit: © Tryfonov - stock.adobe.com
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Image Credit: © abricotine - stock.adobe.com
Image Credit: © alenamozhjer - stock.adobe.com
Related Content
Hidradenitis Suppurative, FDA, Dermatology, Bimzelx | Image Credit: © Gorodenkoff | stock.adobe.com
Published: November 20th 2024 | Updated: November 20th 2024

FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa

Ashley Gallagher, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
Sjogren Disease, FDA, Nipocalimab, Lupus, Rheumatoid Arthritis | Image Credit: © fizkes | stock.adobe.com
November 19th 2024

FDA Grants Breakthrough Therapy Designation for Nipocalimab to Treat Sjögren Disease

Ashley Gallagher, Associate Editor
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Blood cells | Image Credit: © Formoney - stock.adobe.com
November 19th 2024

Abelacimab Reduces Bleeding in AF Patients on Antiplatelet Therapy

Alexandra Gerlach, Associate Editor
AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors
November 18th 2024

AHA 2024: Email Reminders Improve Flu Shot Rates, Particularly Among Heart Attack Survivors

Aislinn Antrim, MA, Assistant Managing Editor